GB2644236A — Orodispersible tablet composition containing carbidopa and levodopa

USPTO Abstract

An orodispersible solid pharmaceutical composition in tablet form is disclosed comprising a) carbidopa and levodopa or pharmaceutically acceptable salts thereof, b) one or more diluent, c) one or more disintegrant, d) at least one lubricant, e) at least one binder and f) one or more pharmaceutically acceptable excipients. The said tablet is manufactured by a wet granulation method. The said tablet prepared using the aforementioned excipients exhibits desirable properties such as facilitating disintegration and dissolution of the drug for oral administration.